Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BMS345541 is predicted as a repurposed drug for the treatment of TMZ-resistant Glioblastoma using target gene expression and virtual drug screening

26 Aug 2024

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to FOXO transcription factor regulation
Share to Glioma Diagnosis and Treatment
Share to MicroRNA in disease regulation

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 39213700
DOI: 10.1016/j.cancergen.2024.08.082

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BMS345541 is predicted as a repurposed drug for the treatment of TMZ-resistant Glioblastoma using target gene expression and virtual drug screeningPMID 39213700Read ↗

Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma.Semantic proximity Read ↗

Repurposing Ivermectin and ATRA as Potential Therapeutics for Glioblastoma MultiformeSemantic proximity Read ↗

Molecular targets of vortioxetine mediating glioblastoma suppression revealed by gene and protein network analyses and molecular docking simulationsSemantic proximity Read ↗

A multistep in silico approach identifies potential glioblastoma drug candidates via inclusive molecular targeting of glioblastoma stem cellsSemantic proximity Read ↗

Characterization of prevalent tyrosine kinase inhibitors and their challenges in glioblastoma treatmentSemantic proximity Read ↗

Repurposing of CNS accumulating drugs Gemfibrozil and Doxylamine for enhanced sensitization of glioblastoma cells through modulation of autophagySemantic proximity Read ↗

“Transcriptomic Profiling Unveils Novel Therapeutic Options for Drug-Resistant Temporal Lobe Epilepsy”Semantic proximity Read ↗

<i>In silico</i> molecular target prediction unveils mebendazole as a potent MAPK14 inhibitorSemantic proximity Read ↗

“The drug development pipeline for glioblastoma - a cross sectional assessment of the FDA Orphan Drug Product designation database”Semantic proximity Read ↗

Drug repurposing for COVID-19 using computational screening: Is Fostamatinib/R406 a potential candidate?Semantic proximity Read ↗

Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression dataSemantic proximity Read ↗

Multi-Omics Analyses Reveal Mitochondrial Dysfunction Contributing to Temozolomide Resistance in Glioblastoma CellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.